Search

everythinglearnresearchcommunity

for

Search:↓

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

The dermal regeneration template is effective in skin regeneration, reducing scarring, and has potential for future improvements.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

COVID-19 may harm male fertility and damage the reproductive system.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Tailored treatment plans are crucial for managing canine dermatomyositis-like disease.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Topical minoxidil showed promise for early male pattern baldness.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

VKHD and sarcoidosis may share a common cause.

Topical sensitizers have mixed success in treating alopecia areata.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

New treatments like nanotechnology show promise in improving skin cancer therapy.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Increased sunscreen use may be linked to frontal fibrosing alopecia in Hispanic females.

Glucocorticoid treatment in lupus can cause oral lesions, which need early diagnosis and comprehensive care.